About FDA
Cumulative number of convictions at the end of the quarter
Dictionary: Cumulative number of OCI criminal convictions, where an individual has plead guilty or been declared guilty by a qualified court for violation of the Food, Drug & Cosmetic Act (FDCA).
Information is current as of February 12, 2013.
Fiscal Year - 2013
| Time | Target | Number of Convictions |
|---|---|---|
| Oct – Dec 2012 | N/A | 47 |
| Jan – Mar 2013 | N/A | TBD |
| Apr – Jun 2013 | N/A | TBD |
| Jul – Sep 2013 | N/A | TBD |
Cumulative amount of money recovered through OCI actions at the end of the quarter
Dictionary: Cumulative monies collected through fines and restitutions imposed by the U.S. Courts for criminal acts enforced under the Food, Drug & Cosmetic Act (FDCA).
Fiscal Year - 2013
| Time | Target | Dollars Recovered |
|---|---|---|
| Oct – Dec 2012 | N/A | 1,271,996,633 |
| Jan – Mar 2013 | N/A | TBD |
| Apr – Jun 2013 | N/A | TBD |
| Jul – Sep 2013 | N/A | TBD |
Footnotes
- Dollars recovered are reported in millions
Number of U.S. Attorney press releases issued relative to OCI investigative activities during the month
Dictionary: Number of U.S. Attorney press releases issued during the reporting period related to OCI criminal investigations (i.e. arrests, convictions and sentencing). Link to OCI press releases.
Fiscal Year - 2013
| Time | Target | Number |
|---|---|---|
| Oct 2012 | N/A | 6 |
| Nov 2012 | N/A | 6 |
| Dec 2012 | N/A | 4 |
| Jan 2013 | N/A | TBD |
| Feb 2013 | N/A | TBD |
| Mar 2013 | N/A | TBD |
| Apr 2013 | N/A | TBD |
| May 2013 | N/A | TBD |
| Jun 2013 | N/A | TBD |
| Jul 2013 | N/A | TBD |
| Aug 2013 | N/A | TBD |
| Sep 2013 | N/A | TBD |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
